Recent Modalities in Treatment of Atopic Dermatitis: Review Article | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 20, Volume 85, Issue 2, October 2021, Page 3596-3603 PDF (556.82 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2021.201968 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Nada Saad Elkady  ; Ayman Elsayed Youssef; Fathia Mohamed Khattab
| ||||
| Abstract | ||||
| Background: Inflammation of the skin marked by itchy, pigmented, dry areas is known as Atopic Dermatitis (AD), also known as Atopic Eczema (AE) or Eczema. Symptoms include red, itchy pimples that leak fluid and crust, scaly or raw skin, or raw or scaly skin. Dermatitis can come in many different forms, such as atopic, contact, or seborrheic. In children, atopic dermatitis is the most prevalent kind of eczema and often occurs in association with other allergic or asthmatic conditions. Eczema is most commonly found on the face, neck, elbows, knees, and toes, among other places. In terms of phototherapy, ultraviolet B phototherapy (280–320 nm) is the "oldest" method that is used in treatment of atopic dermatitis. Platelet rich plasma (PRP) injection utilizes the body's own regenerative mechanisms to help treat disease in the patient. Objective: Determination of the updated treatment modalities in Atopic Dermatitis management. Conclusion: Clearly there remains a need to find more potent topical agents with fewer side effects. The most gratifying advances in AD therapy have come from better understanding of immune and inflammatory mechanisms. | ||||
| Keywords | ||||
| Atopic dermatitis; Ultraviolet B phototherapy; Platelet rich plasma | ||||
|
Statistics Article View: 403 PDF Download: 508 |
||||
